Antivenom Market by Type [Vaccines and Hyperimmune Sera (Homologous & Heterologous)], by Animal (Snakes, Scorpions, Spiders, and Others), and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Antivenom Market by Type [Vaccines and Hyperimmune Sera (Homologous & Heterologous)], by Animal (Snakes, Scorpions, Spiders, and Others), and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1580 | Pages: 184 | December 2016 | Region: Global


The Global Antivenom Market is expected to reach USD 1,493.2 million by 2021 from USD 1,109.5 million in 2016, growing at a CAGR of 6.12% during the forecast period 2016-2021. Antivenom is described as the biological product that detoxifies poisoning of venomous bites. Antivenom is prepared from the milking venom of animals such as snakes, spiders, scorpions, and other venomous animals. Venomous bites result in certain clinical conditions such as secretion of excessive saliva, muscle weakness, breathing problems, and other difficulties that may lead to death also. It is estimated that, approximately 100,000 people die worldwide with snake bites annually. To overcome poisonous effects after venomous bites the global manufacturers developed number of Antivenom products including vaccines and hyperimmune sera.

Increasing government initiations to promote the development of high quality antivenom products, presence of highest number of snake bite victims (especially from Asia & Africa regions), and estimated pipeline products launch are driving the growth of global Antivenom Market. In addition, growing of deaths from venomous animal’s bites and increasing research to develop advanced antivenom products are further stimulating the growth of global Antivenom Market. However, withdrawal of antivenom products, insufficient funding to develop the antivenom products to meet demand, high cost of the products, regulatory complexities, and high costs of maintaining livestock for antivenom production are restraining the growth of global Antivenom Market.

The Global market for Antivenom is broadly categorized into type and animal. On the basis of type, global Antivenom market is segmented into Vaccines and Hyperimmune Sera (Homologous & Heterologous). Based on animal the market is segmented into Snakes, Scorpions, Spiders, and Others.

On the basis of geography, the global market is analysed under various regions namely North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. North America is the dominating market for Antivenom accounting for a share of approximately 39.0% followed by Europe in 2016. Asia-Pacific is estimated to be the fastest growing region with a CAGR of 8.59% during the forecast period of 2016-2021.

Key market players in the global Antivenom market include Instituto Bioclon, S.A. de C.V. (Mexico), Pfizer AG (Switzerland), CSL Limited (Australia), F. Hoffmann-La Roche Ltd. (Switzerland), Merck & Co., Inc. (U.S.), Rare Disease Therapeutics, Inc. (U.S.), Vins Bioproducts Limited (India), BTG Plc (U.K.), Incepta Vaccine Ltd. (Bangladesh), and Bharat Serum and Vaccines Limited (BSV) (India).

1. Introduction                        

            1.1 Market Definition            

            1.2 Study Deliverables                       

            1.3 Base Currency, Base Year and Forecast Periods              

            1.4 General Study Assumptions                     

2. Research Methodology

            2.1 Introduction                     

            2.2 Research Phases              

                        2.2.1 Secondary Research     

                        2.2.2 Primary Research         

                        2.2.3 Econometric Modelling

                        2.2.4 Expert Validation          

            2.3 Analysis Design                

            2.4 Study Timeline                

3. Overview

            3.1 Executive Summary                     

            3.2 Key Inferences                 

            3.3 Epidemology                    

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

            4.1 Market Drivers                 

            4.2 Market Restraints            

            4.3 Key Challenges                 

            4.4 Current Opportunities in the Market                  

5. Market Segmentation

            5.1 Type                     

                        5.1.1 Introduction      

                        5.1.2 Vaccines

                        5.1.3 Hyperimmune Sera       

                                    5.1.3.1 Homologous

                                    5.1.3.2 Heterologous

                        5.1.4  Y-o-Y Growth Analysis, By type            

                        5.1.5  Market Attractiveness Analysis, By Type         

                        5.1.6  Market Share Analysis, By Type           

            5.2 Animal                  

                        5.2.1 Introduction      

                        5.2.2 Snakes   

                        5.2.3 Scorpions           

                        5.2.4 Spiders  

                        5.2.5 Others   

                        5.2.6  Y-o-Y Growth Analysis, By Animal       

                        5.2.7  Market Attractiveness Analysis, By Animal     

                        5.2.8  Market Share Analysis, By Animal       

6. Geographical Analysis

            6.1 Introduction                     

                        6.1.1 Regional Trends

                        6.1.2 Impact Analysis 

                        6.1.3 Y-o-Y Growth Analysis  

                                    6.1.3.1 By Geographical Area

                                    6.1.3.2 By Type

                                    6.1.3.2 By Animal

                        6.1.4  Market Attractiveness Analysis

                                    6.1.4.1 By Geographical Area

                                    6.1.4.2 By Type

                                    6.1.4.2 By Animal

                        6.1.5  Market Share Analysis 

                                    6.1.5.1 By Geographical Area

                                    6.1.5.2 By Type

                                    6.1.5.2 By Animal

            6.2 North America                 

                        6.1.1 Introduction      

                        6.1.2 United States    

                        6.1.3 Canada  

            6.3 Europe                  

                        6.2.1 Introduction      

                        6.2.2 U.K         

                        6.2.3 Spain     

                        6.2.4 Germany

                        6.2.5 Italy       

                        6.2.6 France   

            6.4 Asia-Pacific                       

                        6.3.1 Introduction      

                        6.3.2 China     

                        6.3.3 India      

                        6.3.4 Japan     

                        6.3.5 Australia

                        6.3.6 South Korea      

            6.5 Latin America                   

                        6.4.1 Introduction      

                        6.4.2 Brazil     

                        6.4.3 Argentina          

                        6.4.4 Mexico  

                        6.4.5 Rest of Latin America   

            6.6 Middle East & Africa                    

                        6.5.1 Introduction      

                        6.5.2 Middle-East       

                        6.5.3 Africa    

7.Strategic Analysis                            

            7.1 PESTLE analysis                

                        7.1.1 Political 

                        7.1.2 Economic          

                        7.1.3 Social     

                        7.1.4 Technological    

                        7.1.5 Legal     

                        7.1.6 Environmental  

            7.2 Porter’s Five analysis                   

                        7.2.1 Bargaining Power of Suppliers  

                        7.2.2 Bargaining Power of Consumers          

                        7.2.3 Threat of New Entrants

                        7.2.4 Threat of Substitute Products and Services     

                        7.2.5 Competitive Rivalry within the Industry           

8.Market Leaders' Analysis                            

            8.1 Instituto Bioclon, S.A. de C.V.                  

                        8.1.1 Overview           

                        8.1.2 Product Analysis

                        8.1.3 Financial analysis          

                        8.1.4 Recent Developments   

                        8.1.5 SWOT analysis  

                        8.1.6 Analyst View     

            8.2 Pfizer AG              

            8.3 CSL Limited                      

            8.4 Roche                   

            8.5 Merck & Co                      

            8.6 Rare Disease Therapeutics, Inc.               

            8.7 Vins Bioproducts Limited             

            8.8 BTG Plc                 

            8.9 Incepta Vaccine Ltd                      

            8.10 Bharat Serim and Vaccines Limited (BSV)                     

9. Competitive Landscape                              

            9.1 Market share analysis                  

            9.2 Merger and Acquisition Analysis             

            9.3 Agreements, collaborations and Joint Ventures             

            9.4 New Product Launches                

10. Market Outlook and Investment Opportunities                           

Appendix                                

            a) List of Tables

            b) List of Figures

  • Global, Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Global Diabetes Care Devices Market By Region, From 2016-2021 ( USD Million )
  2. Global Antivenom Market By Type, From 2016-2021 ( USD Million )
  3. Global Vaccines Market By Region, From 2016-2021 ( USD Million )
  4. Global Hyperimmune Sera Market By Region, From 2016-2021 ( USD Million )
  5. Global Antivenom Market By Animal, From 2016-2021 ( USD Million )
  6. Global Snakes Market By Region, From 2016-2021 ( USD Million )
  7. Global Scorpions Market By Region, From 2016-2021 ( USD Million )
  8. Global Spiders Market By Region, From 2016-2021 ( USD Million )
  9. Global Others Market By Region, From 2016-2021 ( USD Million )
  10. North America Antivenom Market By Type, From 2016-2021 ( USD Million )
  11. North America Vaccines Market By Region, From 2016-2021 ( USD Million )
  12. North America Hyperimmune Sera Market By Region, From 2016-2021 ( USD Million )
  13. North America Antivenom Market By Animal, From 2016-2021 ( USD Million )
  14. North America Snakes Market By Region, From 2016-2021 ( USD Million )
  15. North America Scorpions Market By Region, From 2016-2021 ( USD Million )
  16. North America Spiders Market By Region, From 2016-2021 ( USD Million )
  17. North America Others Market By Region, From 2016-2021 ( USD Million )
  18. United States Antivenom Market By Type, From 2016-2021 ( USD Million )
  19. United States Antivenom Market By Animal, From 2016-2021 ( USD Million )
  20. Canada Antivenom Market By Type, From 2016-2021 ( USD Million )
  21. Canada Antivenom Market By Animal, From 2016-2021 ( USD Million )
  22. Europe Antivenom Market By Type, From 2016-2021 ( USD Million )
  23. Europe Vaccines Market By Region, From 2016-2021 ( USD Million )
  24. Europe Hyperimmune Sera Market By Region, From 2016-2021 ( USD Million )
  25. Europe Antivenom Market By Animal, From 2016-2021 ( USD Million )
  26. Europe Snakes Market By Region, From 2016-2021 ( USD Million )
  27. Europe Scorpions Market By Region, From 2016-2021 ( USD Million )
  28. Europe Spiders Market By Region, From 2016-2021 ( USD Million )
  29. Europe Others Market By Region, From 2016-2021 ( USD Million )
  30. U.K. Antivenom Market By Type, From 2016-2021 ( USD Million )
  31. U.K. Antivenom Market By Animal, From 2016-2021 ( USD Million )
  32. Germany Antivenom Market By Type, From 2016-2021 ( USD Million )
  33. Germany Antivenom Market By Animal, From 2016-2021 ( USD Million )
  34. France Antivenom Market By Type, From 2016-2021 ( USD Million )
  35. France Antivenom Market By Animal, From 2016-2021 ( USD Million )
  36. Italy Antivenom Market By Type, From 2016-2021 ( USD Million )
  37. Italy Antivenom Market By Animal, From 2016-2021 ( USD Million )
  38. Spain Antivenom Market By Type, From 2016-2021 ( USD Million )
  39. Spain Antivenom Market By Animal, From 2016-2021 ( USD Million )
  40. Asia-Pacific Antivenom Market By Type, From 2016-2021 ( USD Million )
  41. Asia-Pacific Vaccines Market By Region, From 2016-2021 ( USD Million )
  42. Asia-Pacific Hyperimmune Sera Market By Region, From 2016-2021 ( USD Million )
  43. Asia-Pacific Antivenom Market By Animal, From 2016-2021 ( USD Million )
  44. Asia-Pacific Snakes Market By Region, From 2016-2021 ( USD Million )
  45. Asia-Pacific Scorpions Market By Region, From 2016-2021 ( USD Million )
  46. Asia-Pacific Spiders Market By Region, From 2016-2021 ( USD Million )
  47. Asia-Pacific Others Market By Region, From 2016-2021 ( USD Million )
  48. Japan Antivenom Market By Type, From 2016-2021 ( USD Million )
  49. Japan Antivenom Market By Animal, From 2016-2021 ( USD Million )
  50. China Antivenom Market By Type, From 2016-2021 ( USD Million )
  51. China Antivenom Market By Animal, From 2016-2021 ( USD Million )
  52. India Antivenom Market By Type, From 2016-2021 ( USD Million )
  53. India Antivenom Market By Animal, From 2016-2021 ( USD Million )
  54. Australia Antivenom Market By Type, From 2016-2021 ( USD Million )
  55. Australia Antivenom Market By Animal, From 2016-2021 ( USD Million )
  56. South Korea Antivenom Market By Type, From 2016-2021 ( USD Million )
  57. South Korea Antivenom Market By Animal, From 2016-2021 ( USD Million )
  58. Latin America Antivenom Market By Type, From 2016-2021 ( USD Million )
  59. Latin America Vaccines Market By Region, From 2016-2021 ( USD Million )
  60. Latin America Hyperimmune Sera Market By Region, From 2016-2021 ( USD Million )
  61. Latin America Antivenom Market By Animal, From 2016-2021 ( USD Million )
  62. Latin America Snakes Market By Region, From 2016-2021 ( USD Million )
  63. Latin America Scorpions Market By Region, From 2016-2021 ( USD Million )
  64. Latin America Spiders Market By Region, From 2016-2021 ( USD Million )
  65. Latin America Others Market By Region, From 2016-2021 ( USD Million )
  66. Brazil Antivenom Market By Type, From 2016-2021 ( USD Million )
  67. Brazil Antivenom Market By Animal, From 2016-2021 ( USD Million )
  68. Argentina Antivenom Market By Type, From 2016-2021 ( USD Million )
  69. Argentina Antivenom Market By Animal, From 2016-2021 ( USD Million )
  70. Mexico Antivenom Market By Type, From 2016-2021 ( USD Million )
  71. Mexico Antivenom Market By Animal, From 2016-2021 ( USD Million )
  72. Middle East & Africa Antivenom Market By Type, From 2016-2021 ( USD Million )
  73. Middle East & Africa Vaccines Market By Region, From 2016-2021 ( USD Million )
  74. Middle East & Africa Hyperimmune Sera Market By Region, From 2016-2021 ( USD Million )
  75. Middle East & Africa Antivenom Market By Animal, From 2016-2021 ( USD Million )
  76. Middle East & Africa Snakes Market By Region, From 2016-2021 ( USD Million )
  77. Middle East & Africa Scorpions Market By Region, From 2016-2021 ( USD Million )
  78. Middle East & Africa Spiders Market By Region, From 2016-2021 ( USD Million )
  79. Middle East & Africa Others Market By Region, From 2016-2021 ( USD Million )
  80. Middle East Antivenom Market By Type, From 2016-2021 ( USD Million )
  81. Middle East Antivenom Market By Animal, From 2016-2021 ( USD Million )
  82. Africa Antivenom Market By Type, From 2016-2021 ( USD Million )
  83. Africa Antivenom Market By Animal, From 2016-2021 ( USD Million )

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, Kakatiya's Empire,
Jubilee Gardens, Hyderabad,
Telangana, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.